KLK3 and cancer: Patients with no chronic condition or fewer comorbidities (≤2) as well as patients in early stages of cancer (stage 1 and 2) were more likely to be diagnosed following asymptomatic PSA testing than those with more comorbidites or diagnosed at late stage.